IMII, anyone remember this one???
Intelligent Medical Imaging, Inc. Receives Multi-Unit Purchase Order From Prestigious Cancer Hospital
PALM BEACH GARDENS, Fla.--(BUSINESS WIRE)--March 15, 1999--
University of Texas - MD Anderson Cancer Center, Ranked
No. 2 Cancer Hospital In Nation, Becomes Next Institution
To Acquire MICRO21 Systems
Intelligent Medical Imaging, Inc. (Nasdaq:IMII) today announced that it has received a purchase order for two MICRO21 Systems, the Company's intelligent, automated microscope system, from the University of Texas - MD Anderson Cancer Center. In August, 1998, according to a poll of physicians, U.S. News and World Report named MD Anderson Cancer Center as the second best cancer treatment facility in the United States, led only by Memorial Sloan-Kettering Cancer Center (No. 1) and followed most notably by John Hopkins Hospital (No. 3) and the Mayo Clinic (No. 4).
Tyce Fitzmorris, Chairman, CEO and President of Intelligent Medical Imaging Systems, Inc., stated, "MD Anderson is yet another prestigious and high ranking medical institution which has recognized the invaluable contribution that our MICRO21 System can add to its proven cancer research and diagnostic capabilities. The decision to purchase multiple systems was based primarily on their understanding of how the MICRO21 can significantly improve operational efficiencies and effectively deal with the acute problems often associated with microscopic procedures involving cancer patients. Moreover, we are anxious to have the opportunity to demonstrate that the MICRO21 System can manage even their most extreme cases."
Intelligent Medical Imaging, Inc. (IMII) is the premier designer and manufacturer of intelligent automated microscopic systems. The Company developed and globally markets the MICRO21 System, an intelligent, automated microscope system; the HSM, an automated blood slide maker; and the USM(tm), an automated urine slide maker for diagnostic use in hospitals, commercial reference, physician group practice laboratories and pharmaceutical and veterinary laboratories. IMII's systems are currently in operation at some of the world's most prestigious medical teaching and healthcare institutions including Emory University, Vanderbilt University, Cleveland Clinic, Beth Israel, University of Illinois, Walter Reed Memorial Hospital, Bethesda Naval Medical College, and Cedar Sinai. Partnering with healthcare giant Beckman-Coulter (NYSE:BEC) and global pharmaceutical leader Bayer Corporation via global distribution and/or licensing agreements, IMII is engaged in marketing its products in the United States, Europe, Japan, Israel and Korea.
Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: The statements which are not historical facts contained in this press release are forward-looking statements that involve certain risks and uncertainties including but not limited to risks associated with the uncertainty of future financial results, additional financing requirements, continued listing on the Nasdaq Small Cap market, development and marketing of new products,domestic and offshore government approval processes, the impact of competitive products or pricing, technological changes, the effect of global economic conditions and other uncertainties detailed in the Company's filings with the Securities and Exchange Commission.
CONTACT:
Intelligent Medical Imaging, Inc., Palm Beach Gardens
Tyce M. Fitzmorris, Chairman, CEO & President
561/627-0344
or
Continental Capital & Equity Corp., Longwood, Fla.
Investor/Media Relations: Mark Abernathy
Broker/Institutional Relations: Brendan Hopkins
407/682-2001 |
